by
Thomas Dworetzky, Contributing Reporter | January 06, 2017
This was the third test case for the implants. One earlier led to a $500 million verdict. In 2014 the two firms were cleared in the initial case over the devices.
The next bellwether trial concerns 10 patients, and has been slated for September 2017 in Dallas, according to the Lanier Law Firm.
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Lanier said the verdict was "a message loud and clear" that J&J has "a really nasty part of their business they need to clean up," according to Reuters. http://www.reuters.com/article/us-johnson-johnson-verdict-hipimplants-idUSKBN13Q5XF
According to the wire service, a plaintiffs' offer to settle for $1.8 million before trial had been refused by the company.
Although Johnson & Johnson and DePuy deny wrongdoing, they now face almost 8,400 metal-on-metal implant suits. These are now “consolidated” in federal court in Texas.
Test cases such as this one help to establish the price of the remaining claims.
J&J announces array of new projects and partnerships
Despite the legal troubles with implants, J&J continues to forge ahead with 15 new research collaborative projects, which it announced yesterday.
These include efforts on a number of fronts, including 3-D printing, the microbiome and immunotherapy to address challenges such as depression, cancer and diabetes.
So far, over 300 such efforts have begun under the auspices of Johnson & Johnson Innovation.
"We continue to pursue transformative health care solutions and form collaborations that explore the cutting edge of scientific research to achieve our primary goal of improving the quality of patients' lives," Dr. Paul Stoffels, Chief Scientific Officer, Johnson & Johnson, said in a statement. "Through Johnson & Johnson Innovation, we are committed to identifying and advancing novel solutions in areas of significant need and creating customized deal structures with innovators, in an effort to accelerate products to market."
The new deals are in the form of investments, out-licensing and strategic alliances.
One such alliance involves the use of 3-D printing of the knee meniscus. DePuy Synthes Products has formed a collaboration with Aspect Biosystems to develop a prototype artificial meniscus.
Back to HCB News
